Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Inventory (2016 - 2025)

Historic Inventory for Orthofix Medical (OFIX) over the last 16 years, with Q3 2025 value amounting to $174.0 million.

  • Orthofix Medical's Inventory fell 1543.64% to $174.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $174.0 million, marking a year-over-year decrease of 1543.64%. This contributed to the annual value of $189.5 million for FY2024, which is 1472.5% down from last year.
  • Latest data reveals that Orthofix Medical reported Inventory of $174.0 million as of Q3 2025, which was down 1543.64% from $173.0 million recorded in Q2 2025.
  • In the past 5 years, Orthofix Medical's Inventory ranged from a high of $222.5 million in Q2 2023 and a low of $81.6 million during Q2 2021
  • Moreover, its 5-year median value for Inventory was $174.0 million (2025), whereas its average is $155.5 million.
  • Its Inventory has fluctuated over the past 5 years, first soared by 14983.45% in 2023, then tumbled by 2035.64% in 2025.
  • Quarter analysis of 5 years shows Orthofix Medical's Inventory stood at $83.0 million in 2021, then increased by 20.7% to $100.1 million in 2022, then skyrocketed by 121.83% to $222.2 million in 2023, then fell by 14.73% to $189.5 million in 2024, then decreased by 8.13% to $174.0 million in 2025.
  • Its Inventory was $174.0 million in Q3 2025, compared to $173.0 million in Q2 2025 and $174.5 million in Q1 2025.